MYC protein expression is an important prognostic factor in acute myeloid leukemia
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MYC protein expression is an important prognostic factor in acute myeloid leukemia
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2018-05-10
DOI
10.1080/10428194.2018.1464158
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD34 + Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome
- (2018) Pere Barba et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia
- (2016) Farhad Ravandi et al. CANCER
- Acute myeloid leukaemia: expression of MYC protein and its association with cytogenetic risk profile and overall survival
- (2016) Muhammad Kashif Mughal et al. HEMATOLOGICAL ONCOLOGY
- Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype
- (2016) Yang O. Huh et al. Cancer Genetics
- Should older adults with AML receive post-remission therapy?
- (2015) Richard M. Stone BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?
- (2015) R Peffault de Latour et al. BONE MARROW TRANSPLANTATION
- TP53 overexpression is an independent adverse prognostic factor inde novomyelodysplastic syndromes with fibrosis
- (2015) Sanam Loghavi et al. BRITISH JOURNAL OF HAEMATOLOGY
- hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies
- (2015) Miguel Gallardo et al. CANCER CELL
- Prognostic Significance ofNPM1Mutations in the Absence ofFLT3–Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report
- (2015) Fabiana Ostronoff et al. JOURNAL OF CLINICAL ONCOLOGY
- c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia
- (2015) Bing Xia et al. LEUKEMIA RESEARCH
- Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation
- (2015) Maro Ohanian et al. Cancer Genetics
- MYC through miR-17-92 Suppresses Specific Target Genes to Maintain Survival, Autonomous Proliferation, and a Neoplastic State
- (2014) Yulin Li et al. CANCER CELL
- Identification of clinically important chromosomal aberrations in acute myeloid leukemia by array-based comparative genomic hybridization
- (2014) Meenakshi Mehrotra et al. LEUKEMIA & LYMPHOMA
- Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
- (2014) J. Zhang et al. SCIENCE
- BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients
- (2013) Daniela Damiani et al. AMERICAN JOURNAL OF HEMATOLOGY
- The demarcation between younger and older acute myeloid leukemia patients: A pooled analysis of 3 prospective studies
- (2013) Masamitsu Yanada et al. CANCER
- Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia
- (2013) M A Dawson et al. LEUKEMIA
- Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients
- (2012) Stefan Faderl et al. CANCER
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- MYC oncogene in myeloid neoplasias
- (2012) M. Dolores Delgado et al. Clinical & Translational Oncology
- New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: Cancer and leukemia group B 8461
- (2012) Alison Walker et al. GENES CHROMOSOMES & CANCER
- Survival for older patients with acute myeloid leukemia: a population-based study
- (2012) B. Oran et al. HAEMATOLOGICA
- Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Nathalie A. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulation of gene transcription by the oncoprotein MYC
- (2011) Bernhard Lüscher et al. GENE
- Has there been progress in the treatment of older patients with acute myeloid leukemia?
- (2010) Harry P. Erba BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Comprehensive genomic screens identify a role for PLZF-RAR as a positive regulator of cell proliferation via direct regulation of c-MYC
- (2009) K. L. Rice et al. BLOOD
- Myc's broad reach
- (2008) M. Eilers et al. GENES & DEVELOPMENT
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started